help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 63, No. 1 180-191
doi:10.1210/jcem-63-1-180
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MILEWICH, L.
Right arrow Articles by CARR, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MILEWICH, L.
Right arrow Articles by CARR, B. R.

Human Fetal Liver Estrogen 16{alpha}-Hydroxylase:Precursor Specificity, Kinetic Parameters, and in Vitro Regulation*

LEON MILEWICH, PAUL C. MACDONALD, ALIREZA GUERAMI, WILLIAM T. MIDGETT, WRIGHT L. LASSITER and BRUCE R. CARR

Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Departments of Obstetrics and Gynecology and Biochemistry, The University of Texas Southwestern Medical School Dallas, Texas 75235

Address all correspondence and requests for reprints to: Dr. Leon Milewich, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, Texas 75235.

The properties of human fetal liver (HFL) estrogen 16{alpha}-hydroxylase (16{alpha}-0Hase) were studied in microsomal preparations and hepatocytes maintained in culture. A specific assay was developed for the determination of estrogen 16{alpha}- OHase activity based on the enzymatic release of tritium from the C-16{alpha} position of stereospecifically labeled 16{alpha}-3H-labeled C18-steroids, viz. 17β-[16{alpha}-3H]estradiol, 17βl6{alpha}-3H]estradiol3- sulfate, [16{alpha}-3H]estrone, and [16{alpha}-3H]estrone sulfate. The percentage of tritium at the C-16{alpha} position of 17β[16{alpha}-3H]estradiol was 92.5%. There was no kinetic isotope effect in the 16{alpha}hydroxylation of 17β[16{alpha}-3H]estradiol. HFL hepatocyte and microsomal 16{alpha}-OHase activity was linear with incubation time for at least 2 h, with a hepatocyte number up to 6.7 x 106 cells/ml and a microsomal protein concentration up to 1 mg/ml. The apparent Km of 16{alpha}-OHase for estrone sulfate (E1S) was greater than that for either 17β-estradiol (E2) or estrone (El; 2.9–6.4 µM us. 0.70–0.84 µM). The maximum velocity of HFL 16{alpha}-OHase also was greater with ElS or 17β-estradiol 3-sulfate than with either El or E2, and ElS was the most efficient substrate. The apparent temperature optimum for the microsomal enzyme was 37 C, and the apparent pH optimum was 7.0.16{alpha}-Hydroxylation of ElS by HFL microsomes was inhibited noncompetitively by El. The biosynthesis of estriol from E2 by fetal liver microsomes does not require an intermediate oxidation step of E2 to El as appears to be the case in vivo in the human adult; this was demonstrated by the formation of [17{alpha}-3H]estriol from [17{alpha}-3H] E2 in incubations with HFL microsomes. A number of growth factors, hormones, and xenobiotics were preincubated with hepatocytes for 24 or 72 h to test for stimulation/inhibition of 16a-OHase activity. 16{alpha}-OHase activity was stimulated by dexamethasone, forskolin, (Bu)2cAMP, cholera toxin, 1,2-benzanthracene, and phenobarbital. Diethylstilbestrol, E2, and progesterone did not alter hepatocyte 16{alpha}-OHase activity, except when very high concentrations of E2 and progesterone were used, when they became inhibitory; other hormones and growth factors did not alter the basal levels of the enzyme.

* This work was supported in part by USPHS Grants 5-P50-HD-11149 and HD-17814.

Received December 10, 1985.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. S. Leeder, R. Gaedigk, K. A. Marcucci, A. Gaedigk, C. A. Vyhlidal, B. P. Schindel, and R. E. Pearce
Variability of CYP3A7 Expression in Human Fetal Liver
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 626 - 635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society